Dube Michael P - Insider Non-Derivative Transactions at Intellia Therapeutics, Inc. (NTLA) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Oct 1, 2025, Dube Michael P's relationship to Intellia Therapeutics, Inc. (NTLA) is Officer (VP, Chief Accounting Officer), and currently has 55,266 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other NTLA insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

Dube Michael P - Insider Non-Derivative Transactions of NTLA Common Stock

Dube Michael P - Insider Non-Derivative Transactions at NTLA

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Oct 2, 2025	Sell -- (Common Stock)	1871	17.38	55266
Jul 3, 2025	Sell -- (Common Stock)	2503	9.95	57137
Mar 2, 2025	Acquisition -- (Common Stock)	14000	0	59640
Jan 4, 2025	Sell -- (Common Stock)	1372	12.18	45640
Oct 3, 2024	Sell -- (Common Stock)	2012	19.01	47012
Jul 2, 2024	Acquisition -- (Common Stock)	17801	0	49024